Co-Authors
This is a "connection" page, showing publications co-authored by Andrew Arndt and Christopher Seder.
Connection Strength
1.629
-
Redefining the Risk of Surgery for Clinical Stage IIIA (N2) Non-Small Cell Lung Cancer: A Pooled Analysis of the STS GTSD and ESTS Registry. Lung. 2021 06; 199(3):311-318.
Score: 0.732
-
Sarcopenia after induction therapy is associated with reduced survival in patients undergoing esophagectomy for locally-advanced esophageal cancer. J Thorac Dis. 2021 Feb; 13(2):861-869.
Score: 0.180
-
Understanding barriers to lung cancer screening in primary care. J Thorac Dis. 2020 May; 12(5):2536-2544.
Score: 0.171
-
Serum Biomarkers May Prognosticate Recurrence in Node-Negative, Non-Small Cell Lung Cancers Less Than 4 Centimeters. Ann Thorac Surg. 2017 Nov; 104(5):1637-1643.
Score: 0.143
-
Durability of Silicone Airway Stents in the Management of Benign Central Airway Obstruction. Lung. 2017 10; 195(5):601-606.
Score: 0.140
-
Number of Ribs Resected is Associated with Respiratory Complications Following Lobectomy with en bloc Chest Wall Resection. Lung. 2016 08; 194(4):619-24.
Score: 0.129
-
Consensus for Thoracoscopic Lower Lobectomy: Essential Components and Targets for Simulation. Ann Thorac Surg. 2022 11; 114(5):1895-1901.
Score: 0.047
-
Cannabis Use Is Associated With Recurrence After Primary Spontaneous Pneumothorax. Front Surg. 2021; 8:668588.
Score: 0.046
-
Improved False-Positive Rates and the Overestimation of Unintended Harm from Lung Cancer Screening. Lung. 2019 06; 197(3):327-332.
Score: 0.040